Fmoc-Lys(Dde)-OH is a protected amino acid derivative used as a building block in solid-phase peptide synthesis. The compound features a fluorenylmethoxycarbonyl (Fmoc) group for N-terminal protection and a Dde group for orthogonal protection of the lysine side chain.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 150629-67-7
(2S)-4-[[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid
pharmaceutical intermediate
N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-lysine
pharmaceutical intermediate
N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-2,4-diaminobutyric acid
pharmaceutical intermediate
2-Chloro-3-methylbenzoic acid
pharmaceutical intermediate
4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide
pharmaceutical intermediate
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine
pharmaceutical intermediate
O1-tert-butyl O3-ethyl cis-4-hydroxypiperidine-1,3-dicarboxylate
pharmaceutical intermediate
Fmoc-D-Lys(Dde)-OH
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)ethylideneamino]hexanoic acid
AOHSSQNORWQENF-VWLOTQADSA-N
CC(=NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C4=C(CC(CC4=O)(C)C)O